Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA microbicide meeting

This article was originally published in The Tan Sheet

Executive Summary

Design of antimicrobial clinical trials will be discussed at an April 15-16 meeting sponsored by FDA and the Infectious Diseases Society of America, agency announces in Federal Register March 9. The public workshop will include input from interested groups on trial endpoints, drug development. Topics mirror those covered at a mid-2003 meeting of the FDA Antiviral Drugs Advisory Committee (1"The Tan Sheet" Aug. 25, 2003, p. 7). Meeting will take place at the Center for Drug Evaluation & Research, 5630 Fishers Lane, Rockville, Md...
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS096580

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel